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1. Introduction  
Osteoporosis is a skeletal disease characterized by bone loss and structural deterioration of 
the bone tissue, leading to an increase in bone fragility and susceptibility to fractures, most 
frequently in the hip, wrist and spine (Sendur et al., 2009). Bone loss is associated with such 
factors as age, menopause in women, smoking, alcohol excess, calcium and vitamin D 
deficiency, low weight and muscle mass, anticonvulsant and corticosteroid use as well as 
certain co-morbid conditions such as rheumatoid arthritis (Javaid et al., 2008). Worldwide, it 
has been estimated that fractures caused by osteoporosis account for approximately one in 
three among women and approximately one in five among men over the age of 50. 
Although the mechanisms underlying osteoporosis are not fully understood, there is 
evidence suggesting that oxidative stress caused by reactive oxygen species (ROS) is 
associated with its pathogenesis (Sahnoun et al., 1997; Basu et al., 2001; Rao et al., 2007). 
Oxidative stress is a condition that can be characterized by an imbalance of pro-oxidants 
and antioxidants with the scale being tipped towards an excess of pro-oxidants, creating 
abnormally high concentrations of ROS. ROS are a family of highly reactive, oxygen-
containing molecules and free radicals, including hydroxyl (OH·–) and superoxide radicals 
(O2·–), hydrogen peroxide (H2O2), singlet oxygen, and lipid peroxides (Juránek and Bezek, 
2005). Several recent studies reported the impact of oxidative stress on osteoclast 
differentiation as well as on its function resulting to an increase in bone resorption (Garrett 
et al., 1990; Bax et al., 1992; Mody et al., 2001; Lean, 2003). Furthermore, recent in vitro studies 
have shown the important detrimental role of ROS on osteoblast activity (Park et al., 2005; Bai 
et al., 2004; Bai et al., 2005). In addition to in vitro and animal models, there is also increasing 
clinical evidence that oxidative stress might be involved in the pathogenesis of osteoporosis 
(Melhus et al., 1999; Sontakke & Tare., 2002; Basu et al., 2001; Maggio et al., 2003).  
Antioxidants are known to mitigate the damaging effects of oxidative stress on cells. 
Epidemiological evidence has indicated a link between dietary intake of antioxidants and bone 
health. Fruits and vegetables are important sources of antioxidant phytochemicals that have 
been shown to play an important role in bone metabolism. Higher consumption of fruits and 
vegetables has been correlated with a reduction in the risk for the development of osteoporosis. 
(Arikan et al., 2011; Prentice et al., 2006; Macdonald et al., 2004; Macdonald et al., 2008; Palacios 
et al., 2006; Tucker et al., 1999; Lister et al., 2007; New, 2003; Trzeciakiewicz et al., 2009).  
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Category Subclass Structure 
Common 
Flavonoid 
Food Examples 
Phenolic acids 
Hydroxycinnamic 
acids 
 
Caffeic acid coffee beans 
Hydroxybenzoic 
acids 
  
Gallic acid 
gallnuts, sumac, 
witch hazel, tea 
leaves, oak bark, 
Flavonoids 
Anthocyanidins Cyanidin 
berries, purple 
cabbage, beets, 
grape seed 
extract, and red 
wine 
Flavanols  
 
Catechins 
white, green 
and black teas 
Theaflavins black teas 
Proanthocyanidins 
chocolate, fruits 
and vegetables, 
red wine, onion, 
apple skin 
Flavanones  
  
Hesperidin citrus fruits 
Narigenin citrus fruits 
Silybin 
blessed milk 
thistle 
Flavonols 
  
Quercetin 
red and yellow 
onions, tea, 
wine, apples, 
cranberries, 
buckwheat, 
beans 
Flavones  
 
Apigenin 
chamomile, 
celery, parsley 
Tangeritin 
tangerine and 
other citrus 
peels 
Luteolin 
celery, thyme, 
green pepers,  
Isoflavones  
  
Genistein 
soy, alfalfa 
sprouts, red 
clover, 
chickpeas, 
peanuts, other 
legumes. 
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Stilbenes 
  
Resveratrol 
gapes skins, red 
wine 
Lignans 
  
Secoisolaiciresinol flaxseeds 
Table 1. The different categories of polyphenols, their chemical structures and sources 
Of particular interest among the antioxidant phytochemicals present in fruits and vegetables are 
the polyphenols. Polyphenols can be sub classified as non-flavonoids and flavonoids. Ellagic 
acid and stilbenes are among the major non-flavonoid polyphenols. Included in the flavonoid 
polyphenols are the anthocyanins, catechins, flavones, flavonols and isoflavones. The different 
categories of polyphenols, their chemical structures and sources are shown in Table 1.  
Numerous studies have shown the health-promoting properties of polyphenols, providing 
additional mechanisms through which they promote skeletal health by reducing resorption 
caused by high oxidative stress (Trzeciakiewicz et al., 2009; Tucker, 2009; Hunter et al., 2008). 
The antioxidant properties of polyphenols have been widely studied and reported in the 
literature (Liu et al., 2005; Miyamoto et al.,1998; Rassi et al., 2002; Viereck et al., 2002; Ward et 
al., 2001; Shen et al., 2011; Rao et al., 2007). They strongly support the role of polyphenols in 
the delayed onset or reduction in the progression of osteoporosis. The protective effects of 
polyphenols against diseases, including osteoporosis, have generated new expectations for 
improvements in health. This review will focus mainly on the role of polyphenols in 
osteoporosis and present results of studies undertaken in our laboratory. 
2. Oxidative stress, antioxidants and osteoporosis 
Oxidative stress occurs when the production of free radicals through a number of cellular 
events exceeds the ability of the cell’s antioxidant defense to eliminate these oxidants (Baek 
et al., 2010). These free radicals have the ability to change the integrity of, and thus, damage 
several biomolecules, such as DNA, proteins and lipids (Baek et al., 2010). There is 
increasing evidence that oxidative stress is responsible for the pathophysiology of the aging 
process and may also be involved in the pathogenesis of atherosclerosis, neurodegenerative 
diseases, cancer, and diabetes. Recently, ROS were shown to be responsible for the 
development of osteoporosis (Sahnoun et al., 1997; Basu et al., 2001; Rao et al., 2007; Altindag 
et al., 2008; Becker, 2006; Feng & McDonald, 2011). Several in vitro and animal studies have 
shown that oxidative stress diminishes the level of bone formation by reducing the 
differentiation and survival of osteoblasts (Baek et al., 2010). Furthermore, it has been 
reported that ROS activate osteoclasts and thus, enhance bone resorption (Baek et al., 2010). 
The presence of ROS in osteoclasts was also demonstrated by Rao et al. in 2003 Recent 
evidences from a few clinical studies have also revealed that ROS and/or antioxidant 
systems might play a role in the pathogenesis of bone loss (Rao et al., 2007; Mackinnon et al., 
2010; Abdollahi et al., 2005). 
A number of studies have shown that antioxidants have a fundamental role in preventing 
postmenopausal osteoporosis. For instance, estrogens, whose antioxidant activity is essential 
in protecting women of reproductive age from cardiovascular disease, stimulate osteoblastic 
activity through specific receptors, thus favouring bone growth (Banfi et al., 2008). Antioxidant 
deficiency has been shown to have adverse effect on bone mass (Maggio et al. 2003).  
www.intechopen.com
 
Phytochemicals – A Global Perspective of Their Role in Nutrition and Health 
 
470 
Antioxidant enzymes are regarded as the markers of antioxidant defense mechanism against 
bone resorption. Several studies have investigated the relationship between antioxidant 
enzymes such as glutathione peroxidase (GPx) and catalase (CAT) and osteoporosis 
(MacKinnon et al., 2011; Hahn et al., 2008; Maggio et al., 2003; Sontakke & Tare, 2002).  
Recently, many dietary antioxidant nutrients have also been reported to decrease the 
oxidative stress that takes part in bone-resorptive processes (Rao et al., 2007; Weber, 2001; 
Peters & Martini, 2010; Macdonald et al., 2004). In addition to the antioxidant enzymes and 
nutrients, studies have also been directed towards the role of antioxidant phytochemicals 
such as the carotenoids in osteoporosis which will not be covered here, but has previously 
been reviewed (Rao & Rao, 2007; Sahni et al., 2009; Tucker, 2009).  
 
Fig. 1. The role of oxidative stress in osteoporosis and how/where antioxidants play a role 
in mitigating ROS 
3. Natural phytochemical antioxidants 
Within the last decade, there has been an increased interest on polyphenols as a result of the 
in vitro evidence demonstrating that they may have numerous benefits to human health, 
mainly due to their antioxidative and free radical quenching properties (Hendrich, 2006; 
Lotito & Frei 2006; Heinonen, 2007; Stevenson & Hurst 2007; Aron & Kennedy 2008; Lopez-
Lazaro, 2009; Saura-Calixto et al. 2007). It is therefore hypothesized that polyphenols may 
aid in the prevention of aging-associated diseases, particularly cardiovascular diseases, 
cancers, and osteoporosis.  
Polyphenolic compounds are the products of the secondary metabolism of plant and are an 
essential part of human diet (Goldberg, 2003; Stevenson & Hurst 2007; D’Archivio et al., 
2007; Saura-Calixto et al. 2007). To date, more than 8,000 polyphenols that have one common 
structural feature have been identified, a phenol, which is an aromatic ring possessing at 
least one hydroxyl substituent (Hendrich, 2006; Scalbert & Williamson, 2000; Harborne, 
1993). The main classes of polyphenols include phenolic acids, flavonoids, stilbene, and 
lignans (Spencer et al., 2008; D’Archivio et al., 2007). Figure 1 illustrates the different groups 
of polyphenols, the chemical structures and food sources. Their total dietary intake can 
range up to 1 gram/day, which is considerably higher than that of all other classes of 
phytochemicals (Velioglu et al., 1998). There is much evidence demonstrating that 
polyphenols improve the status of different oxidative stress biomarkers. However, there is 
uncertainty regarding both the relevance of these biomarkers as predictors of disease risk 
and the appropriateness of the different methods used.  
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Polyphenol 
Class Reference 
Principal 
polyphenol Model Main findings 
Phenolic 
Acids 
Papoutsi et 
al., (2008) 
Ellagic acid (10-
100nM) 
KS483 ↑ nodule formation 
  Ayoub et al., 
(2009) 
3-methoxyellagic acid 
(25ug/ml) 
HOS58 & SaOS-2 ↑ mineralization of bone cell 
Flavonoids Zhang et al. 
(2009) 
Naringin bone mesenchymal 
stem cells (BMSCs) 
Dose-specific (1–100 μg/ml) of the 
naringin solution may enhance the 
proliferation and osteogenic 
differentiation of human BMSCs 
  Choi (2007) Apigenin MC3T3-E1 cells Apigenin (0.01 mM) increased the 
growth of MC3T3-E1 cells and caused a 
significant elevation of alkaline 
phosphatase (ALP) activity and 
collagen content in the cells 
  Kim et al. 
(2011) 
Luteolin Bone marrow cells 
were prepared by 
removing from the 
femora and tibiae of 
ICR mice 
luteolin decreased differentiation of 
both bone marrow mononuclear cells 
and Raw264.7 cells into osteoclasts, 
inhibited the bone resorptive activity of 
differentiated osteoclasts.  
  Choi (2011) Kaempferol MC3T3-E1 cells induced the activation of PI3K 
(phosphoinositide 3-kinase), Akt 
(protein kinase B), and CREB (cAMP-
response element-binding protein). 
This may prevent or reduce 
degerneration of osteoblasts 
  Wattel et al. 
(2004) 
Quercetin RAW 264.7 cells, 
peripheral blood 
monocytic cells 
(PBMC) 
Quercetin (0.1–10 mM) decreased 
osteoclastogenesis in a dose dependent 
manner in both models with significant 
effects observed at low concentrations, 
from 1 to 5 mM 
Isoflavones Sugimoto & 
Yamaguchi 
(2000) 
Daidzein MC3T3-E1 cells increase alkaline phosphatase activity 
  Rassi et al. 
(2002) 
Daidzein osteoclasts from 
young female piglets 
inhibits development of osteoclasts 
from cultures of porcine bone marrow 
and reduces bone resorption 
  Viereck et al. 
(2002) 
Genistein mature human 
osteoblasts (hOB) 
up-regulated OPG production 2–6-fold 
in a time- and dose-dependent manner, 
neutralizing RANKL 
Lignans Hasegawa et 
al. (2010) 
Honokiol bone marrow cells of 
6wk old mice 
Inhibits osteoclast differentiation by 
suppressing the activation of MAPKs 
(p38 MAPK, ERK and JNK) 
Stilbenes Chang et al. 
(2006) 
Piceatannol immortalized fetal 
osteoblasts (hFOB), 
and osteosarcoma 
cells (MG-63) 
piceatannol increased BMP-2 synthesis, 
induced osteoblasts maturation and 
differentiation 
  Kupisiewicz 
et al. (2010) 
Modified resveratrol 
analogues 
Myeloma cell lines 
U266 and OPM-2 
Resveratrol analogues showed an up to 
5,000-fold increased potency to inhibit 
osteoclast differentiation and promoted 
osteoblast maturation compared to 
resveratrol.  
Table 2. Polyphenols- In vitro studies 
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4. Polyphenols and osteoporosis 
There has been an increase interest in the field of bone health and nutrients, and within the 
last decade, it has been well recognized that some polyphenols, whether ingested as 
supplements or with food, do in fact improve bone health status. Currently, most of the 
research on polyphenols and their effects has emerged from in vitro and in vivo studies with 
only a few clinical studies available. Compounds present in fruits and vegetables influence 
bone health as shown with in vitro osteoblast cell culture. On the other hand, epidemiologic 
studies tend to have mixed results with regards to the protective effects of polyphenol 
consumption against osteoporosis. Tables 2, 3, and 4 illustrate some of the recent in vitro, in 
vivo and clinical studies that have been reported in the literature, respectively.  
 
Polyphenol 
Class Reference Substance given 
Principal 
polyphenol Model 
Dose per 
day Main findings 
Phenolic 
Acids 
Chen (2010) Blueberries Phenolic acid 
mixture 
Sprague-
Dawley rats
  Increase serum 
osteoblast progenitors, 
increased osteoblast 
differentiation, reduced 
osteoclastogenesis, 
increase bone mass 
  Zych et al. 
(2010) 
  Ferulic,caffeic, p-
coumaric, 
chlorogenic, 
clohexanecarbox
ylic acid 
Wistar 
Cmd:(WI)W
U rats 
10 mg/kg 
p.o. 
caffeic acid worsened 
bone mechanical 
properties 
  Folwarczna 
et al. (2010) 
  Curcumin Wistar 
Cmd:(WI)W
U rats 
10 mg/kg, 
po 
no sig. improvement of 
bone mineralizasation 
or mechanical 
properties 
  Folwarczna 
et al. (2009) 
  Caffeic, p-
coumaric, 
chlorogenic acid 
Wistar 
Cmd:(WI)W
U rats 
10 mg/kg 
p.o. 
caffeic acid ↓ bone 
mass, p-coumaric acid ↑ 
bone mass/body mass 
ratio and bone mineral 
mass/body mass ratio 
in long bones 
Flavonoids Devareddy 
et al. (2008) 
Blueberries Variety of 
phenolic acids 
and flavonols 
OVX rat 5% w/w Ovx resulted in loss of 
whole-body, tibial, 
femoral, and 4th 
lumbar BMD by 
approximately 6%. 
Blueberry treatment 
was able to prevent the 
loss of whole-body 
BMD and had an 
intermediary effect on 
prevention of tibial and 
femoral BMD 
  Arjmandi et 
al. (2010) 
(1) 2% 
Fructooligosacchari
des (FOS); 5% 
FOS+7.5% DP; 2% 
FOS+5% DP; 2% 
FOS+2% DP 
Variety OVX rat   diet of 5% FOS + 7.5% 
dried plum was most 
effective in reversing 
both right femur and 
fourth lumbar BMD 
and fourth lumbar 
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polyphenol 
(equivalent to 7.5% 
DP powder); (5) 2% 
FOS+7.5% DP 
juice; (6) 2% 
FOS+7.5% DP 
puree; (7) 2% 
FOS+7.5% DP pulp 
skins; (8) 2% 
FOS+7.5% raisin; 
(9) 2% FOS+7.5% 
fig; (10) 2% 
FOS+7.5% date; 
(11) 2% FOS+7.5% 
blueberry; (12) 2% 
FOS+0.25% HMB; 
and (13) 0.25% 
HMB. 
calcium loss while 
significantly decreasing 
trabecular separation. 
No significant effects of 
treatment on serum or 
urine measures of bone 
turnover. 
  Shen et al. 
(2008) 
Green tea 
polyphenols (GTP)
(-)Epigallocatechin 
gallate 
OVX rat 0.1% or 0.5% 
concentratio
n of GTP in 
drinking 
water 
GTP supplementation 
increased urinary 
epigallocatechin and 
epicatechin 
concentrations, femur 
BMD, decreased 
urinary 8-hydroxy-2′-
deoxyguanosine and 
urinary calcium levels; 
no effect on serum 
estradiol 
  Shen et al. 
(2010) 
Green tea 
polyphenols (GTP)
(-)Epigallocatechin 
gallate 
40 female 
CD rats 
0.5% 
concentratio
n of GTP in 
drinking 
water 
GTP supplementation 
increased urinary 
epigallocatechin and 
epicatechin 
concentrations and 
showed higher values 
for femur BMC, BMD 
and serum OC, but 
lower values for serum 
TRAP, urinary 8-OHdG 
and spleen mRNA 
expression of TNF-α 
and COX-2 levels. 
  Shen et al. 
(2011) 
Green tea 
polyphenols (GTP)
(-)Epigallocatechin 
gallate 
50 OVX  0.5% 
concentratio
n of GTP in 
drinking 
water 
GTP supplementation 
resulted in increased 
serum osteocalcin 
concentrations, bone 
mineral density, and 
trabecular volume, 
number, and strength 
of femur; increased 
trabecular volume and 
thickness and bone 
formation in both the 
proximal tibia and 
periosteal tibial shaft 
  Das et al. 
(2005) 
Black tea extract Theaflavin Bilaterally 
oophorecto
2.5% 
aqueous 
BTE increase serum 
estradiol level  
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mized rats BTE at a 
single dose 
of 1 ml /100 
g body 
weight 
  Chiba et al. 
(2003) 
hesperidin & α-
glucosylhesperidin
Hesperidin & α-
glucosylhesperid
in 
OVX mice 0.5 g/100 g 
hesperidin, 
0.7 g/100 g 
α-
glucosylhes
peridin 
hesperidin or α-
glucosylhesperidin 
restored BMD caused 
by OVX, α-
glucosylhesperidin 
significantly prevented 
loss of trabecular bone 
volume and trabecular 
thickness in the femoral 
distal metaphysis 
  Park et al. 
(2008) 
apigenin Apigenin OVX rats 10 mg/kg apigenin increased the 
mineral content and 
density of the 
trabecular bone at the 
neck of the left femur, 
decreased body weight 
and dietary 
consumption 
  Kim et al. 
(2011) 
luteolin Luteolin OVX mice 5 and 20 
mg/kg 
luteolin increased bone 
mineral density and 
bone mineral content of 
trabecular and cortical 
bones in the femur as 
compared to those of 
OVX controls 
  Do et al. 
(2008) 
Rubus coreanus Anthocyanin OVX rats 100 & 200 
mg/kg 
RCM increased femur 
trabecular bone area in 
a dose-dependent 
manner in 
ovariectomized rats, 
increased osteoblast 
differentiation and 
osteoclast apoptosis. 
  Horcajada-
Molteni et 
al. (2000) 
Rutin Rutin OVX rats 2.5 g/kg Rutin prevented 
decrease in both total 
and distal metaphyseal 
femoral mineral density 
by slowing down 
resorption and 
increasing osteoblastic 
activity caused by OVX, 
Isoflavones Arjmandi et 
al. (1998) 
Soy protein Genistein 72 OVX rats 1462 mg/kg 
genistein, 
25.1 mg/kg 
daidzin, 11.3 
mg/kg 
daidzein 
no effect on BMC 
  Lee et al. 
(2004) 
Soybean Glycitein 24 OVX rats 6.25 g/kg soybean isoflavone 
appear to prevent bone 
loss in femur and 
lumber vertebrae via a 
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different mechanism of 
estrogen 
  Miyamoto et 
al (1998) 
8-
isopentenylnaringe
nin 
8-
isopentenylnarin
genin 
OVX rats 30 mg/day  8-isopentenyl 
naringenin prevented 
decrease in BMD and 
bone turnover markers 
Lignans Xiao et al. 
(2011) 
Sambucus 
williamsii HANCE 
(SWH) 
Lignans 56 OVX/6J 
specific-
pathogen-
free (SPF) 
female mice
17b-
oestradiol 
(3·2 mg/kg), 
SWH (60% 
ethanol 
crude 
extract; 1·0 
g/kg), SWA 
(water 
eluate; 0·570 
g/kg), SWB 
(30% ethanol 
eluate; 0·128 
g/kg) or 
SWC (50 and 
95% ethanol 
eluates; 
0·189 g/kg) 
SWC significantly 
restored bone mineral 
density and improved 
bone size and bone 
content in femur and 
tibia 
  El-Shitany et 
al. (2010) 
Silymarin Silymarin OVX rats 50 mg/kg protected trabecula 
thickness, decreased 
serum levels of ALP 
and increased serum 
levels of both calcium 
and phosphorus 
  Ward et al. 
(2001) 
Flaxseed Secoisolariciresin
ol diglucoside 
20 Sprague-
Dawley 
male rats 
293 μmol 
SDG/kg 
exposure to a diet with 
flaxseed during 
lactation through to 
early adolescence can 
reduce bone strength, 
but lignan does is not 
the mediator, no sig. 
change in BMD and 
BMC those fed flaxseed 
Stilbenes Pearson et 
al. (2008) 
Resveratrol Resveratrol Male 
C57BL/6NI
A mice 
100 mg/kg 
or 400 
mg/kg 
Both diets improved 
distal trabecular tissue 
mineral density (TMD) 
and bone volume to 
total volume ratio over 
the entire femur 
compared to control 
  Liu et al. 
(2005) 
trans-Resveratrol Resveratrol OVX rat 0.7 mg/kg epiphysis BMD and 
bone calcium content 
was significantly 
greater with resveratrol 
treatment than that in 
the OVX group, no 
differences in femoral 
midpoint BMD 
Table 3. Polyphenols- In vivo Studies 
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Polyphenol 
Class Reference 
Substance 
given 
Principal 
polyphenol Model Dose per day Main findings 
Flavonoids Hardcastle 
et al. (2011) 
None Catechin perimenopausal 
Scottish women 
  flavanones were 
negatively 
associated with 
bone-resorption 
markers, 
association 
between energy-
adjusted total 
flavonoid intakes 
and BMD at the 
femoreal neck and 
lumbar spine, 
annual percent 
change in BMD 
was associated 
with intakes of 
procyanidins and 
catechins 
Isoflavones Chen et al. 
(2004) 
Soy 
isoflavone 
Daizein 203 
postmenopausal 
women 
placebo: 0 mg 
isoflavones + 500 
mg calcium, mid-
dose:40 mg 
isoflavones+ 500 
mg calcium, 
high-dose:80 mg 
isoflavones + 500 
mg calcium 
no effect on BMD 
in all groups, 
effect of soy 
isoflavones on 
BMC at the total 
hip and trochanter 
was less strong in 
women in early 
menopause or in 
those with higher 
body weight, 
nonsignificantin 
BMC in those with 
a high level of 
dietary calcium 
intake 
  Arjmandi et 
al. (2005) 
Soy protein Daizein 87 
postmenopausal 
women 
25 g protein and 
60 mg 
isoflavones 
Whole body and 
lumbar BMD and 
BMC significantly 
decreased, and 
BSAP and 
osteocalcin 
increasedin 
control and soy 
groups 
  Kenny et al. 
(2009) 
Soy protein 
+ isoflavone 
tablets 
Isoflavones 131 
postmenopausal 
women >65 
years old 
18 g soy protein 
and 105 mg 
isoflavone tablets
no differences in 
BMD 
Lignans Cornish et 
al. (2009) 
Flaxseed Secoisolaricir
esinol 
diglucoside 
50 men, 50 
postmenopausal 
women 
  no effect on BMD 
  Dodin et al. 
(2005) 
Flaxseed Secoisolaricir
esinol 
diglucoside 
199 menopausal 
women 
  no sig. change in 
BMD 
Table 4. Polyphenols - Clinical Studies 
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There have been several results suggesting that the combination of polyphenolic compounds 
found naturally in fruits and vegetables may reduce the risk of osteoporosis via increasing 
bone mineral density (Wu et al., 2002; Morton et al., 2001; Melhus et al., 1999; Leveille et al., 
1997; Singh, 1992). In 1992, Singh was able to show that polyphenols afford protection against 
oxidative stress-induced bone damage during strenuous exercise. Similarly, Melhus was able 
to show its counteractive effect of polyphenols among smokers (Melhus et al., 1999).  
5. Research results on the role of polyphenols in osteoporosis from the 
author’s laboratory  
Previous in vitro results from our laboratory have shown that a supplement rich in a variety 
of polyphenols commercially known as greens+TM, is more effective in stimulating  
 
Fig. 2. Dose dependent effect of greens+TM (g+) and epicatechin (EC) compared to vehicle. 
(p<0.05)  
 
Fig. 3. Time and dose-dependent effects of bone builderTM on mineralized bone nodule area 
in Sa0S-2 cells (p< 0.05).  
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osteoblasts to form more bone nhodules in a dose-dependant manner than epicatechin, the 
main polyphenol found in green tea (Fig. 2). Our laboratory also studied the effects of a 
second supplement, bone builderTM, which is rich in minerals, vitamins and nutrients. 
Similarly to the greens+TM, the water-soluble bone-builder extract had a significant dose-
dependent stimulatory effect on bone nodules formation (Fig. 3). Figure 4 shows that when 
the two supplements, greens+TM and bone builderTM, were tested as combination, the effects 
were six times more effective than either one alone. This led us to believe that synergistic 
effects of greens+TM and bone builderTM may have a beneficial effect on osteoporosis. We 
then conducted a clinical evaluation of this nutritional supplement greens+ bone builderTM 
Results have shown that there was an increase in total antioxidant capacity after 8 weeks of 
treatment compared to placebo (Fig 4). as well as a decrease in both lipid and protein 
oxidation over a 4 and 8-weeks of intervention with greens+ bone builderTM compared to 
placebo (Fig. 6 & 7). This suggests that the nutritional supplement may have a beneficial 
effect on bone health by mitigating the effects of oxidative stress.  
 
Fig. 4. Dose Dependent Effect of greens + (g+) with and without 0.5 mg/ml of bone builder 
(bb) on the area of mineralized bone nodules in osteoblasts Sa0S-2 Cells. * p<0.0005, 
**p<0.005; ***p<0.05; # p<0.0001; ## p<0.001; ### p<0.01; significance differences were 
found when treatment with g+ plus 0.5 mg/ml bb was compared to treatment with g+ alone 
as follows: a\b< 0.0001; bp< 0.005  
 
Fig. 5. The effect of nutritional intervention with g+bbTM compared to placebo on serum 
total antioxidant capacity (p<0.05). 
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Fig. 6. Change in TBARS over 4 and 8-weeks of nutritional intervention with g+bbTM 
compared to placebo (p<0.001). 
 
Fig. 7. Change in protein oxidation over 4 and 8-weeks of nutritional intervention with 
g+bbTM compared to placebo (p<0.05). 
6. Conclusions 
Although epidemiologic studies are practical for the evaluation of human health effects on 
the physiologic concentrations of polyphenols, reliable data on polyphenol contents of foods 
are limited. This review has shown that polyphenols or polyphenol-rich diets can provide 
significant protection or treatment for the development and progression of osteoporosis. 
Keeping in mind that many nutrients are co-dependent, and they may interact among 
themselves and others. The complexity of these interactions may possibly be the reason why 
many studies show controversial or inconsistent results regarding the effects of a single 
nutrient or groups of nutrients in bone health. Based on current knowledge, polyphenols 
offer a platform for the prevention of many human chronic diseases involved with oxidative 
stress, including osteoporosis.  
To value the actual significance of food phenolics, it is necessary to investigate not only 
their bioavailability, but also their mechanisms of action and their possible synergism 
with other constituents either in the diet or within the human body, as well as the 
polyphenolic content and composition of foods. We have attained this goal by studying 
the nutritional supplement greens+TM, which is rich in polyphenols and their interactions 
with minerals, vitamins and nutrients that were present in the nutritional supplement 
bone builderTM. 
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